BMO Capital on Y-mAbs Therapeutics (YMAB): 'Radiopharma Is Hot & SADA De-Risking Would Unlock Value'

Go back to BMO Capital on Y-mAbs Therapeutics (YMAB): 'Radiopharma Is Hot & SADA De-Risking Would Unlock Value'
(NASDAQ: YMAB) Delayed: 8.61 --0 (-0%)
Previous Close $8.61    52 Week High
Open $8.61    52 Week Low
Day High $8.61    P/E N/A 
Day Low $8.61    EPS
Volume 6,496,971